If you review the PPMD 'latest research' page they are currently advocating for combinations in therapies with the thesis that they will be more effective. I can't post the link for some reason.
The way I see it someone like Sarepta would have little to lose by trialling their drug in combo. It keeps good will with the ppmd community and keeps their company and drug front and centre in treatment of this disease. Sarepta are all in on DMD and cannot afford to stand still and watch others beat them to the punch.
- Forums
- ASX - By Stock
- anp chart
If you review the PPMD 'latest research' page they are...
-
- There are more pages in this discussion • 681 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.1¢ |
Change
-0.002(2.41%) |
Mkt cap ! $75.72M |
Open | High | Low | Value | Volume |
8.4¢ | 8.4¢ | 8.1¢ | $36.29K | 444.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 106250 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 38888 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 106250 | 0.080 |
3 | 132078 | 0.079 |
2 | 120924 | 0.078 |
2 | 46800 | 0.075 |
1 | 100000 | 0.074 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 38888 | 1 |
0.083 | 59708 | 2 |
0.085 | 136669 | 3 |
0.086 | 27375 | 1 |
0.087 | 531562 | 3 |
Last trade - 11.23am 04/09/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |